Xavier Fournie

WORK HISTORY

EDUCATION

SKILLS

ABOUT XAVIER FOURNIE

Xavier Fournie, MD was an Executive Medical Director, Scientific Medical Affairs at ICON Commercialization and Outcomes until February 2021. He provides medical and scientific expertise in support of operational strategy and execution of studies as a free-lance Consultant. He hold various leadership posts in Late-phase and post-authorisation research over 35 years. These posts included but were not limited to: market research and clinical research project management, leading of clinical operations, general management of central lab activities, medical direction, Quality Assurance and Regulatory Affairs direction, Drug safety development. In 1995, he created a company so called Genematic, specialized in the development of e-tools for clinical research. From 2001 to the end of 2008, as a CEO, Xavier Fournie has led the development of this organization (renamed PROCLINICA) by extending its services to a company dedicated to multi-country direct-to-patient management for proactive PRO data collection and patient assistance in studies. Mapi Group Corporate Medical Director and EVP, Global Medical Affairs of Mapi RWE, he was in charge of the development and maintenance of professional relationships with a variety of audiences, oversight of medical monitoring services, developed a culture of ethical and regulatory compliance across Mapi business units and helped to develop and implement new services and strategic plans into the Mapi Group before acquisition by Icon. Dr Fournie practiced as a GP in hospitals and private practices and has degrees in Medical Law, Sport and Aeronautic Medicine. He holded a part time position as a Regulating Doctor for emergency medical services (SAMU) of Lyon area and is currently holding a consulting physician position for prefrail patients at Pierre Garraud hospital in Lyon where he set up a rehabilitation program so called \"Vitage\". He is an active member of two ENCePP/EMA Working Groups (“Research Standards and Guidances; Independence and Transparency”) and co-chair of EUCROF PharmacoVigilance working group. Specialties: Medical Doctor, CRO, Medical Affairs, Medical Law, Quality Assurance, Clinical trials and Pharmaco-Epidemiological studies, Regulatory Affairs, Direct Patient Management, Pharmacovigilance